Location History:
- Manitoba, CA (2006)
- Winnipeg, CA (2012)
Company Filing History:
Years Active: 2006-2012
Title: The Innovative Contributions of Anthony Shaw
Introduction
Anthony Shaw is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of medical diagnostics, particularly in the analysis of blood serum components. With a total of 2 patents to his name, Shaw's work has the potential to impact cardiovascular health assessments.
Latest Patents
Shaw's latest patents include a groundbreaking method and test for blood serum component analysis. This invention leverages the discovery that apolipoprotein B exhibits identifiable spectral features in the mid-infrared spectrum within blood serum. By establishing a statistical correlation between the concentration of apolipoprotein B (apoB) in a blood serum sample and its infrared spectral features, Shaw has developed a test for apoB. Additionally, he has patented a method for the simultaneous and direct determination of serum cholesterol in both high and low-density lipoproteins using infrared spectroscopy. This method allows for the simultaneous measurement of cardiovascular risk markers, including High Density Lipoprotein cholesterol (HDL-C), Low Density Lipoprotein cholesterol (LDL-C), total cholesterol, triglycerides, and oxidized LDL.
Career Highlights
Shaw is currently affiliated with the National Research Council of Canada, where he continues to advance his research in medical diagnostics. His innovative approaches have garnered attention in the scientific community, contributing to the development of more effective diagnostic tools.
Collaborations
Shaw has collaborated with esteemed colleagues, including Kan-Zhi Liu and Henry H Mantsch, to further enhance the impact of his research. Their combined expertise has led to significant advancements in the field.
Conclusion
Anthony Shaw's contributions to medical diagnostics through his innovative patents demonstrate his commitment to improving health outcomes. His work in blood serum analysis is paving the way for more accurate cardiovascular risk assessments.